B. Moura

Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management

A. Hottinger, T. Hundsberger, Christophoros Astaras, 2018, Current Neurology and Neuroscience Reports.

Management of Primary CNS Lymphoma in Elderly Patients

A. Hottinger, F. Grandoni, R. Micheli, 2017 .

Progression , Pseudoprogression & radiation necrosis in high grade gliomas

A. Hottinger, B. Moura, 2017 .

[New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities].

O. Michielin, K. Homicsko, J. Cerottini, 2015, Revue medicale suisse.

Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels.

R. Stupp, A. Hottinger, A. Idbaih, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma

V. Zoete, O. Michielin, P. Tsantoulis, 2023, International journal of molecular sciences.